/lifesciences?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Life Sciences Copyright 2025 ¼«ËÙÈü³µ. en-US Fri, 01 Aug 2025 23:36:39 +0000 /lifesciences/articles/2372590?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2372590 A California federal jury Friday found Meta Platforms Inc. liable for violating the state's wiretap law by using a data analytics tool to retrieve sensitive health data from users of the popular menstrual tracking app Flo, in what plaintiffs' counsel called "one of the first times" a major tech company has been held accountable for such practices.  Fri, 01 Aug 2025 22:58:11 +0000 /lifesciences/articles/2371280?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371280 In this special edition of Wheeling & Appealing, we're spotlighting key decisions and developments in every circuit court during the first half of 2025, while also previewing August's most intriguing oral arguments, including a remarkably "fierce" showdown between Edible Arrangements and 1-800-Flowers with millions of dollars in attorney fees on the line. Fri, 01 Aug 2025 22:45:36 +0000 /lifesciences/articles/2370813?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2370813 Acting U.S. Patent and Trademark Office Director Coke Morgan Stewart dismissed most of the 50 petitions for inter partes review addressed in her latest decisions over discretionary denials at the Patent Trial and Appeal Board. Fri, 01 Aug 2025 21:22:38 +0000 /lifesciences/articles/2372031?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2372031 Patent challengers at the Patent Trial and Appeal Board will no longer be able to skirt a requirement that they must identify where all the elements of the patent are found in prior art patents or printed publications, according to a notice from the U.S. Patent and Trademark Office. Fri, 01 Aug 2025 21:02:35 +0000 /lifesciences/articles/2372408?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2372408 The Trump administration has improperly "weaponized" federal laws against drug misbranding, false claims and female genital mutilation as part of a pressure campaign to undermine state protections for gender-affirming care, a coalition of state attorneys general argued in a new suit Friday. Fri, 01 Aug 2025 20:08:58 +0000 /lifesciences/articles/2372243?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2372243 A majority en banc Ninth Circuit has affirmed a lower court's decision upholding Los Angeles Unified School District's COVID-19 vaccine mandate for employees, while two partially dissenting judges disagreed with the majority's conclusion that the policy passes constitutional muster. Fri, 01 Aug 2025 19:45:32 +0000 /lifesciences/articles/2372536?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2372536 A coalition of 16 states pressed the U.S. Supreme Court on Friday to reject the Trump administration's push to resume the mass termination of scientific research grants, saying a district judge had authority to pause the cuts. Fri, 01 Aug 2025 17:37:10 +0000 /lifesciences/articles/2372291?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2372291 The U.S. Department of Justice abandoned its challenge of a corporate travel management deal, while lawmakers are calling for scrutiny of the agency's recent decision to settle a different case, and the Federal Trade Commission agreed to nix the requirements placed on a pair of oil and gas deals. Fri, 01 Aug 2025 17:25:20 +0000 /lifesciences/articles/2371427?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371427 The U.S. Department of Justice's recently effective data security requirements carry profound implications for how healthcare providers collect, store, share and use data — and approach vendor oversight — that go far beyond the Health Insurance Portability and Accountability Act, say attorneys at Nelson Mullins. Fri, 01 Aug 2025 16:56:27 +0000 /lifesciences/articles/2367457?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2367457 After the U.S. Supreme Court recently struck down the practice of nationwide injunctions in Trump v. Casa, Section 1983 civil rights suits can provide a better pathway to hold the government accountable — but this will require reforms to qualified immunity, says Marc Levin at the Council on Criminal Justice. Fri, 01 Aug 2025 16:22:29 +0000 /lifesciences/articles/2372278?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2372278 Pharmacy benefit manager OptumRx has moved to disqualify Motley Rice LLC from representing the state of Utah in an opioid crisis lawsuit, claiming the firm clearly violated ethical rules by investigating OptumRx on behalf of government entities, then suing OptumRx in a private capacity. Fri, 01 Aug 2025 15:17:30 +0000 /lifesciences/articles/2371438?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371438 In contrast with the Biden administration, the second Trump administration has signaled a renewed willingness to resolve merger enforcement concerns through remedies from the outset, particularly when the proposed fix is structural, clearly addresses the harm and does not require burdensome oversight, say attorneys at Cooley. Fri, 01 Aug 2025 14:29:54 +0000 /lifesciences/articles/2372159?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2372159 A California federal judge will block Johnson & Johnson's Biosense Webster from refusing clinical support for its Carto cardio mapping systems from hospitals that use competitors' cardiac catheters, requiring the company to institute nondiscriminatory pricing for its services at hospitals regardless of which products they use. Fri, 01 Aug 2025 13:05:40 +0000 /lifesciences/articles/2371453?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371453 The Supreme Court recently declined to revisit the contentious framework governing patent eligibility by denying certiorari in Audio Evolution Diagnostics v. U.S., suggesting a necessary recalibration of both patent application and litigation strategies, say attorneys at Skadden. Thu, 31 Jul 2025 20:59:03 +0000 /lifesciences/articles/2371682?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371682 A professional pharmacy organization and a group of teaching hospitals teed up motions to dismiss Wednesday against proposed class action allegations that they conspired to restrict wages and benefits by funneling new pharmacists through a job-matching program, telling a Maryland federal judge that there's no sign of an agreement. Thu, 31 Jul 2025 20:43:59 +0000 /lifesciences/articles/2371704?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371704 Biotechnology company Scynexis Inc. has won dismissal, for now, of a proposed investor class action alleging that it triggered a 34% share decline by knowingly misleading investors about manufacturing compliance issues that led to a drug recall, with the court finding the allegations the company should have known and disclosed issues only show "fraud by hindsight." Thu, 31 Jul 2025 19:01:38 +0000 /lifesciences/articles/2371764?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371764 Surgical Instrument Service Co. Inc. has received backing at the Ninth Circuit from a trade association and others groups as it looks to revive its case accusing Intuitive Surgical Inc. of blocking third parties from refurbishing components for its popular da Vinci surgery robot. Thu, 31 Jul 2025 17:00:11 +0000 /lifesciences/articles/2371768?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371768 Eighteen Republican U.S. senators urged President Donald Trump to appoint someone to the vacant role of chief innovation and intellectual property negotiator of the U.S. Trade Representative in order to work to remove what they called "market-distorting price controls" in the pharmaceutical industry. Thu, 31 Jul 2025 16:51:54 +0000 /lifesciences/articles/2371850?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371850 The Trump administration on Thursday announced plans for a pilot project that would allow certain drugmakers to abandon upfront discounts in the 340B program and instead require hospitals to apply for rebates, testing an idea that would fundamentally reshape the long-running program. Thu, 31 Jul 2025 16:42:16 +0000 /lifesciences/articles/2371705?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2371705 A Honeywell International Inc. former vice president and general counsel accused the Charlotte-based conglomerate of age discrimination, telling a North Carolina federal court that she was fired for turning 55.